No Data
ARKK's Holdings Ranked by SA Quant Grades
Truist Financial Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Announces Target Price $90
9 Analysts Have This To Say About Intellia Therapeutics
Intellia Therapeutics (NTLA) Gets a Buy From Truist Financial
Oppenheimer Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Cuts Target Price to $60
Intellia Therapeutics Is Maintained at Outperform by Oppenheimer
三和巴菲特 : Have you cried today? Baby
YWCYAPWEICHOY 叶伟财 OP 三和巴菲特 :
YWCYAPWEICHOY 叶伟财 OP 三和巴菲特 : Laughed.
71179109 : Intellia - 20% yesterday